Dr. Sahar Rosenblum, MD

Dr. Rosenblum practices at Ochsner LSU Health - Academic Medical Center in Shreveport, Louisiana, part of Ochsner Health System.

Dr. Rosenblum's NPI, 1457856676, was assigned on March 28, 2018. Dr. Rosenblum graduated from David Geffen School of Medicine at UCLA in 2018. Dr. Rosenblum holds Texas license T7716.

Dr. Rosenblum's primary practice is Ochsner LSU Health - Academic Medical Center, at 1541 Kings Highway, Shreveport, LA 71130 in Caddo Parish. The practice phone is (318) 675-5058.

Dr. Rosenblum's primary practice is Ochsner LSU Health - Academic Medical Center in Shreveport, Louisiana, part of Ochsner Health System. Dr. Rosenblum is also affiliated with University Hospital. The medical group on file is LSU Health Shreveport. Dmand AI also links Dr. Rosenblum to 3 more hospitals and 8 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosenblum practices, 5 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Rosenblum's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dr. Rosenblum is board certified in anesthesiology by the American Board of Anesthesiology. Dmand AI has Dr. Rosenblum's licenses on file in 5 states: Texas, Arizona, Idaho, Nebraska and Massachusetts.

CMS data shows 59 Medicare services from Dr. Rosenblum across 3 procedure codes in 2024, for 151 Medicare patients. Medicare paid $7,277 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 151 Medicare patients who saw Dr. Rosenblum in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rosenblum's median patient age at 58, with 66% women.

In 2019, Dr. Rosenblum wrote 33 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $393 in total drug cost.

Dr. Rosenblum accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Rosenblum, published from 2011 to 2014. 2013 was the busiest year, with 3. The most frequent topics are Acetanilides, Immunohistochemistry and Mice, Inbred BALB C. Dr. Rosenblum has published most often in Mol Imaging Biol. Dr. Rosenblum's most frequent co-authors are Raphael Guzman, MD, Billy W. Loo, MD, PhD and Hongguang Liu, MD.

CMS Open Payments shows 3 general payments to Dr. Rosenblum from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Pacira Pharmaceuticals Incorporated paid the most, $26.

Dr. Rosenblum graduated from David Geffen School of Medicine at UCLA in 2018. Dr. Rosenblum is a member of ASA.

Dr. Rosenblum is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.